Coenzyme Q10 in Post-Cardiac Arrest Cerebral Resuscitation

Completed · Phase 2 · Has a placebo group

Conditions studied: Cardiac Arrest, Sudden Cardiac Arrest

In brief

Specific Aim #1: To determine if levels of CoQ10 are low post-cardiac arrest (CA). We will perform a prospective trial with the primary endpoint of describing the prevalence of low serum CoQ10 levels. Specific Aim #2: To determine if CoQ10 levels in post-CA patients can be increased with the administration of exogenous CoQ10.. We will perform a randomized control trial (RCT) of post-CA patients with the secondary endpoint of comparing CoQ10 levels among those randomized to CoQ10 supplementation vs placebo.

Key facts

Study ID

NCT01319110

Run by

Beth Israel Deaconess Medical Center

People needed

10

Starts

2011-02-01

Expected to finish

2011-12-31

Last updated by the study team

2017-07-31

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients (age > 18 years)
• Comatose after CA with subsequent return of spontaneous circulation

You may not qualify if…

• Comatose status prior to CA
• CoQ10 therapy within one month prior to CA
• Pregnancy

Where it is running

• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.